Certara, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Certara, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $22 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 97% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 32.5 times by its yearly operating cash. Higher than 92% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
4.1×Over the last 3 years its own operating cash covered its investment spending (capex) 4.1 times.
Higher than 83% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
−$20Sales grew 25% in 3 years, but profit fell: $20 less profit per $100 of extra sales.
Lower than 77% of Healthcare companies in United States.
Asset Productivity Ratio
+25% / -1%In 3 years sales changed by +25% while total assets changed by -1%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
32.5×Debt due within a year is covered 32.5 times by its yearly operating cash.
Higher than 92% of Healthcare companies in United States.
Cash Cushion Ratio
−8%Debt, after subtracting cash, equals 8% of its market value (net debt).
Lower than 77% of Healthcare companies in United States.
Tangible Assets Ratio
22%Of every $100 the company owns, $22 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 97% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 77% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Certara, Inc. made a loss over the last year. Certara, Inc. owes $0.31 for every $1 it owns. Certara, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCertara, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.59The share price is 1.59 times Certara, Inc.'s book value per share, lower than 65% of Healthcare companies in United States.
Market cap
$1.5 BThe total market value of all of Certara, Inc.'s shares at today's price (share price × number of shares), larger than 70% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$967 MWhat Certara, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.34Net worth divided by the number of shares. The share price of $10.09 is 1.6 times this, which is the P/B above.
Return on equity (ROE)
-2.2%Certara, Inc. lost 2.2% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
Owes vs Owns
0.31×Certara, Inc. owes $0.31 for every $1 it owns (low), lower than 59% of Healthcare companies in United States.
Dividend yield
NoneCertara, Inc. does not currently pay a dividend.
Revenue growth
+9%Revenue rose 9% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Profit growth
LossCertara, Inc. made a loss in each of the last two years.
Profit margin
-0.4%Certara, Inc. lost $0 for every $100 of revenue.
Interest cover
1.1×Certara, Inc.'s operating profit covered its interest costs 1.1 times in the year to Dec 2025.
Cash vs debt
Net debtCertara, Inc. had $117 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Certara, Inc.: $1.5 B ÷ $967 M (30 Jun 2026) = 1.6.
What is Certara, Inc.'s return on equity?
Certara, Inc. lost 2.2% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
How much does Certara, Inc. owe compared with what it owns?
Certara, Inc. owes $0.31 for every $1 it owns (low), lower than 59% of Healthcare companies in United States.
Does Certara, Inc. pay a dividend?
No. Certara, Inc. does not currently pay a dividend.
Is Certara, Inc.'s revenue growing?
Revenue rose 9% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.